AstraZeneca
(https://onglyza.com) 📸 Data Snapshot: May 31, 2026
Commodity Fingerprint — The Lens
Look at how much sentence length varies. Natural writing varies its rhythm; templated or mass-produced copy is statistically uniform. Very low variation reads as commodity content — unless unique named entities break the pattern.
Commodity Fingerprint
Detection of industry clichés/templates.
13
Impact Weight: 15 / 100
87% Reputation
The site avoids most value proposition clichés, though it uses standard industry boilerplate such as information contained below is intended for US residents only. The value proposition is entirely unique to the brand because the content is a proprietary list of patented medications. Template language is minimal, restricted to utility links and the affordability block. This content could not be copy-pasted onto a competitor because the H3 headers are specific brand names owned by the entity.
Commodity Fingerprint is read from the page structure first: templated copy tends to repeat the same heading patterns and shapes seen across an industry. Below is the heading hierarchy captured, then the known cliché patterns for this industry to weigh it against.
🏗️ Semantic Structure — heading hierarchy & page identity (templated vs. distinct patterns)
HOMEPAGE AstraZeneca Medications (https://onglyza.com)
Title
AstraZeneca Medications
H1 AstraZeneca medications
H2 The list below contains full Prescribing Information for all of our medicines and a range of websites dedicated to providing you with product-specific information. The information contained below is intended for US residents only.
H2 Help affording your medicines
H3 AIRSUPRA™ (albuterol/budesonide)
H3 ANDEXXA® Coagulation Factor Xa (recombinant), inactivated-zhzo
H3 BAXFENDY® (baxdrostat) Tablets
H3 BEVESPI AEROSPHERE® (glycopyrrolate and formoterol fumarate) Inhalation Aerosol
H3 BREZTRI AEROSPHERE® (budesonide, glycopyrrolate, and formoterol fumarate) Inhalation Aerosol
H3 BRILINTA® (ticagrelor) tablets
H3 BYDUREON BCise® (exenatide extended-release) injectable suspension
H3 BYETTA® (exenatide) injection
H3 CALQUENCE® (acalabrutinib) tablets
H3 CRESTOR® (rosuvastatin) Tablets
H3 DALIRESP® (roflumilast) tablets
H3 ENHERTU® (fam-trastuzumab deruxtecan-nxki) injection for intravenous use
H3 EPANOVA® (omega-3-carboxylic acids) Capsules
H3 FARXIGA® (dapagliflozin) tablets
H3 FASENRA® (benralizumab) injection, for subcutaneous use
H3 FASLODEX® (fulvestrant) injection, for intramuscular use
H3 FLUMIST® (Influenza Vaccine Live, Intranasal)
H3 IMFINZI® (durvalumab) injection, for intravenous use
H3 IRESSA® (gefitinib)
H3 KOMBIGLYZE® XR (saxagliptin and metformin HCl extended-release) tablets
H3 LOKELMA® (sodium zirconium cyclosilicate) 10 g for oral suspension
H3 LYNPARZA® (olaparib) tablets
H3 NEXIUM® (esomeprazole magnesium) delayed-release capsules, for oral suspension
H3 NEXIUM® (esomeprazole magnesium) for delayed-release oral suspension
H3 NEXIUM® I.V. (esomeprazole sodium) for injection, for intravenous use
H3 ONGLYZA® (saxagliptin) tablets
H3 PULMICORT RESPULES® (budesonide inhalation suspension)
H3 QTERN® (dapagliflozin and saxagliptin) tablets
H3 SAPHNELO® (anifrolumab-fnia) Injection, for intravenous use
H3 SEROQUEL® (quetiapine) tablets
H3 SEROQUEL XR® (quetiapine) Extended-release tablets
H3 SYMBICORT® (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol
H3 SYMLIN® (pramlintide acetate) injection
H3 TAGRISSO® (osimertinib) tablets
H3 TEZSPIRE® (tezepelumab-ekko) Injection, for subcutaneous use
H3 TRUQAP™ (capivasertib)
H3 WAINUA™ (eplontersen)
H3 XIGDUO® XR (dapagliflozin and metformin HCl extended-release) tablets
H3 Global site
H3 Resources
H3 Quick links
H3 Social Media
H4 utility links
NAV_HEADING_REPEATED_BODY_FOOTER AstraZeneca Medications (https://onglyza.com/medicines/Affordability.html)
Title
AstraZeneca Medications
H1 AstraZeneca medications
H2 The list below contains full Prescribing Information for all of our medicines and a range of websites dedicated to providing you with product-specific information. The information contained below is intended for US residents only.
H2 Help affording your medicines
H3 AIRSUPRA™ (albuterol/budesonide)
H3 ANDEXXA® Coagulation Factor Xa (recombinant), inactivated-zhzo
H3 BAXFENDY® (baxdrostat) Tablets
H3 BEVESPI AEROSPHERE® (glycopyrrolate and formoterol fumarate) Inhalation Aerosol
H3 BREZTRI AEROSPHERE® (budesonide, glycopyrrolate, and formoterol fumarate) Inhalation Aerosol
H3 BRILINTA® (ticagrelor) tablets
H3 BYDUREON BCise® (exenatide extended-release) injectable suspension
H3 BYETTA® (exenatide) injection
H3 CALQUENCE® (acalabrutinib) tablets
H3 CRESTOR® (rosuvastatin) Tablets
H3 DALIRESP® (roflumilast) tablets
H3 ENHERTU® (fam-trastuzumab deruxtecan-nxki) injection for intravenous use
H3 EPANOVA® (omega-3-carboxylic acids) Capsules
H3 FARXIGA® (dapagliflozin) tablets
H3 FASENRA® (benralizumab) injection, for subcutaneous use
H3 FASLODEX® (fulvestrant) injection, for intramuscular use
H3 FLUMIST® (Influenza Vaccine Live, Intranasal)
H3 IMFINZI® (durvalumab) injection, for intravenous use
H3 IRESSA® (gefitinib)
H3 KOMBIGLYZE® XR (saxagliptin and metformin HCl extended-release) tablets
H3 LOKELMA® (sodium zirconium cyclosilicate) 10 g for oral suspension
H3 LYNPARZA® (olaparib) tablets
H3 NEXIUM® (esomeprazole magnesium) delayed-release capsules, for oral suspension
H3 NEXIUM® (esomeprazole magnesium) for delayed-release oral suspension
H3 NEXIUM® I.V. (esomeprazole sodium) for injection, for intravenous use
H3 ONGLYZA® (saxagliptin) tablets
H3 PULMICORT RESPULES® (budesonide inhalation suspension)
H3 QTERN® (dapagliflozin and saxagliptin) tablets
H3 SAPHNELO® (anifrolumab-fnia) Injection, for intravenous use
H3 SEROQUEL® (quetiapine) tablets
H3 SEROQUEL XR® (quetiapine) Extended-release tablets
H3 SYMBICORT® (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol
H3 SYMLIN® (pramlintide acetate) injection
H3 TAGRISSO® (osimertinib) tablets
H3 TEZSPIRE® (tezepelumab-ekko) Injection, for subcutaneous use
H3 TRUQAP™ (capivasertib)
H3 WAINUA™ (eplontersen)
H3 XIGDUO® XR (dapagliflozin and metformin HCl extended-release) tablets
H3 Global site
H3 Resources
H3 Quick links
H3 Social Media
H4 utility links
NAV_HEADING_REPEATED_FOOTER AstraZeneca Medications (https://onglyza.com/az-in-us.html)
Title
AstraZeneca Medications
H1 AstraZeneca medications
H2 The list below contains full Prescribing Information for all of our medicines and a range of websites dedicated to providing you with product-specific information. The information contained below is intended for US residents only.
H2 Help affording your medicines
H3 AIRSUPRA™ (albuterol/budesonide)
H3 ANDEXXA® Coagulation Factor Xa (recombinant), inactivated-zhzo
H3 BAXFENDY® (baxdrostat) Tablets
H3 BEVESPI AEROSPHERE® (glycopyrrolate and formoterol fumarate) Inhalation Aerosol
H3 BREZTRI AEROSPHERE® (budesonide, glycopyrrolate, and formoterol fumarate) Inhalation Aerosol
H3 BRILINTA® (ticagrelor) tablets
H3 BYDUREON BCise® (exenatide extended-release) injectable suspension
H3 BYETTA® (exenatide) injection
H3 CALQUENCE® (acalabrutinib) tablets
H3 CRESTOR® (rosuvastatin) Tablets
H3 DALIRESP® (roflumilast) tablets
H3 ENHERTU® (fam-trastuzumab deruxtecan-nxki) injection for intravenous use
H3 EPANOVA® (omega-3-carboxylic acids) Capsules
H3 FARXIGA® (dapagliflozin) tablets
H3 FASENRA® (benralizumab) injection, for subcutaneous use
H3 FASLODEX® (fulvestrant) injection, for intramuscular use
H3 FLUMIST® (Influenza Vaccine Live, Intranasal)
H3 IMFINZI® (durvalumab) injection, for intravenous use
H3 IRESSA® (gefitinib)
H3 KOMBIGLYZE® XR (saxagliptin and metformin HCl extended-release) tablets
H3 LOKELMA® (sodium zirconium cyclosilicate) 10 g for oral suspension
H3 LYNPARZA® (olaparib) tablets
H3 NEXIUM® (esomeprazole magnesium) delayed-release capsules, for oral suspension
H3 NEXIUM® (esomeprazole magnesium) for delayed-release oral suspension
H3 NEXIUM® I.V. (esomeprazole sodium) for injection, for intravenous use
H3 ONGLYZA® (saxagliptin) tablets
H3 PULMICORT RESPULES® (budesonide inhalation suspension)
H3 QTERN® (dapagliflozin and saxagliptin) tablets
H3 SAPHNELO® (anifrolumab-fnia) Injection, for intravenous use
H3 SEROQUEL® (quetiapine) tablets
H3 SEROQUEL XR® (quetiapine) Extended-release tablets
H3 SYMBICORT® (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol
H3 SYMLIN® (pramlintide acetate) injection
H3 TAGRISSO® (osimertinib) tablets
H3 TEZSPIRE® (tezepelumab-ekko) Injection, for subcutaneous use
H3 TRUQAP™ (capivasertib)
H3 WAINUA™ (eplontersen)
H3 XIGDUO® XR (dapagliflozin and metformin HCl extended-release) tablets
H3 Global site
H3 Resources
H3 Quick links
H3 Social Media
H4 utility links
NAV_HEADING_REPEATED_FOOTER AstraZeneca Medications (https://onglyza.com/medicines/astrazeneca-medications.html)
Title
AstraZeneca Medications
H1 AstraZeneca medications
H2 The list below contains full Prescribing Information for all of our medicines and a range of websites dedicated to providing you with product-specific information. The information contained below is intended for US residents only.
H2 Help affording your medicines
H3 AIRSUPRA™ (albuterol/budesonide)
H3 ANDEXXA® Coagulation Factor Xa (recombinant), inactivated-zhzo
H3 BAXFENDY® (baxdrostat) Tablets
H3 BEVESPI AEROSPHERE® (glycopyrrolate and formoterol fumarate) Inhalation Aerosol
H3 BREZTRI AEROSPHERE® (budesonide, glycopyrrolate, and formoterol fumarate) Inhalation Aerosol
H3 BRILINTA® (ticagrelor) tablets
H3 BYDUREON BCise® (exenatide extended-release) injectable suspension
H3 BYETTA® (exenatide) injection
H3 CALQUENCE® (acalabrutinib) tablets
H3 CRESTOR® (rosuvastatin) Tablets
H3 DALIRESP® (roflumilast) tablets
H3 ENHERTU® (fam-trastuzumab deruxtecan-nxki) injection for intravenous use
H3 EPANOVA® (omega-3-carboxylic acids) Capsules
H3 FARXIGA® (dapagliflozin) tablets
H3 FASENRA® (benralizumab) injection, for subcutaneous use
H3 FASLODEX® (fulvestrant) injection, for intramuscular use
H3 FLUMIST® (Influenza Vaccine Live, Intranasal)
H3 IMFINZI® (durvalumab) injection, for intravenous use
H3 IRESSA® (gefitinib)
H3 KOMBIGLYZE® XR (saxagliptin and metformin HCl extended-release) tablets
H3 LOKELMA® (sodium zirconium cyclosilicate) 10 g for oral suspension
H3 LYNPARZA® (olaparib) tablets
H3 NEXIUM® (esomeprazole magnesium) delayed-release capsules, for oral suspension
H3 NEXIUM® (esomeprazole magnesium) for delayed-release oral suspension
H3 NEXIUM® I.V. (esomeprazole sodium) for injection, for intravenous use
H3 ONGLYZA® (saxagliptin) tablets
H3 PULMICORT RESPULES® (budesonide inhalation suspension)
H3 QTERN® (dapagliflozin and saxagliptin) tablets
H3 SAPHNELO® (anifrolumab-fnia) Injection, for intravenous use
H3 SEROQUEL® (quetiapine) tablets
H3 SEROQUEL XR® (quetiapine) Extended-release tablets
H3 SYMBICORT® (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol
H3 SYMLIN® (pramlintide acetate) injection
H3 TAGRISSO® (osimertinib) tablets
H3 TEZSPIRE® (tezepelumab-ekko) Injection, for subcutaneous use
H3 TRUQAP™ (capivasertib)
H3 WAINUA™ (eplontersen)
H3 XIGDUO® XR (dapagliflozin and metformin HCl extended-release) tablets
H3 Global site
H3 Resources
H3 Quick links
H3 Social Media
H4 utility links
🧭 Industry Context — common cliché & template patterns in Medical Devices, Pharma & Biotech to weigh against
Generic Claims:
advancing human health, breakthrough innovation, life-changing therapies, transforming patient outcomes, pioneering medical science, the future of medicine…
Red Flags:
FDA cleared used interchangeably with FDA approved, clinical claims without published study citations, breakthrough claims for incremental improvements, regulatory status implied but not specified, patient testimonials making efficacy claims, off-label promotion signals…
Semantic Drift Patterns:
homepage claims breakthrough but pipeline page shows preclinical only, FDA approved claims but only for one indication, marketed broadly, claims clinical evidence but links to poster presentations not published studies, claims global reach but regulatory approvals are single-market…
Proof Expectations:
specific regulatory clearance numbers (FDA 510(k), CE, TGA), published clinical trial results with ClinicalTrials.gov registration, ISO 13485 and GMP certification details, peer-reviewed publication citations, specific patent numbers and status, pharmacovigilance and adverse event reporting mechanisms…
Explore the other reputation pillars for AstraZeneca
Analysis Disclosure & Source Attribution
This page presents a snapshot of public data from AstraZeneca, captured on May 31, 2026, to show how machine logic reads Commodity Fingerprint signals into an AI reputation evaluation.
Purpose: This data is presented under “Fair Use” for the purpose of independent signal analysis, allowing readers to see the raw signals behind the reputation score.
Notice to AstraZeneca: This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results are intended as professional feedback to help improve any website’s machine-readability and authority signals. The evaluation is free, and any company can request a fresh audit at any time.
Any company can use the insights for free and improve its voice. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://onglyza.com to view the most current version of its content and see directly what this company is about and what it offers.